BRITISH JOURNAL ©) se de Pn.O) Mo len se Instructions to Authors Nomenclature Guidelines for 2002 i INDEX 2001 VOLUMES 132 — 134 BRITISH JOURNAL OF PHARMACOLOGY ns I | c ad < ( ) CA\ PC Ihe Board of Edito Edited for the British Pharmacological Society by Editor-in-Chief R.A. North Sheffield, UK Senior Editors P.G. Hellewell Sheffield. UK J.J. Lambert Dundee, UK UK A.G. Ramage London, UK Editorial Board Submission of manuscripts ‘ O B BPS Off British Journal of Pharmacology Instructions to Authors Nomenclature Guidelines for Authors Index to Volumes 132, 133 and 134 Author Index Subject Index Subscriptions — Outside the USA Or na i Scope De N Subscriptions — USA USA s Esper Publisher Advertiseme nts 2 i N14 7 I[ Reprints and permissions t Copyright Subscriptions — 2002 subscription rates INSTITUTIONAL SUBSCRIPTIONS Combined (electronic online & print): | Ss Electronic online only Print (hard copy) only: El Pp ; Site licences and institutional online access ‘ p PERSONAL SUBSCRIPTIONS (USA only) Combined (electronic & print) Ss Electronic online only: USS Print (hard copy) only S$ Elite Typesetting Techniques, Eastleigh, Hants Printed on acid free paper effective with Volume 114, Issue | 1995 in i bo ind by Unwin Brothers Ltd The Gresham Press, Old Woking, Surrey British Journal of Pharmacology (2002) 135, 3-9 2 f vJaatt ureo DFiusDhdh ic AP ll rights> res- erved N0N0N0? 7 - 111818/002 0$¢9o2c5C . 070 h{ pd www.nature.com/Djp INSTRUCTIONS TO AUTHORS With effect from | April 2002 The British Journal of Pharmacology welcomes contributions British Journal of Pharmacology in all fields of experimental pharmacology, including neuro- Editorial Office science, biochemical, cellular and molecular pharmacology. 16 Angel Gate, 326 City Road, London ECIV 2SG for publication as full papers or as high priority Special Tel: (0) 020 7417 0432 Fax: (0) 020 7417 0430 Reports, Review Articles and Commentaries. (Please note Commentaries must be commissioned by the Journal) Papers should normally be based on new results obtained FULL PAPERS experimentally and should constitute a significant contribu- tion to pharmacological knowledge. Papers which reassess Manuscripts must be typed in double-line spacing, in type not pharmacological concepts based on earlier results will also be smaller than |1 point with margins of no less than 3 cm and considered as will purely theoretical papers. Papers dealing each page should be numbered. If submitting a hardcopy only with descriptions of methods are acceptable if new manuscripts should be printed on one side of US letter or A4 principles are involved paper and clipped (not stapled) together. Papers in recent issues Contributions that have already been published. Ol of the British Journal of Pharmacology should be consulted for accepted or are under consideration for publication, with the general layout of the paper and also for details. For all essentially the same content will not be considered. This manuscripts the following subsections are used restriction does not apply to results published as abstracts of i" litle page communications, letters to editors, or as contributions to ~ Summary symposia, provided that the submission adds significantly to Introduction the information available in the previously published Methods contribution. Results Papers are only accepted if accompanied by a Declara- Discussion and conclusions tion which must be signed by all Authors his Acknowledgements Declaration concerns the originality of the submitted paper List of references and licences publication to Nature Publishing Group on Tables behalf of the British Pharmacological Society. See page 7 10. Legends for details 11. Figures The Journal will not consider papers which describe experi- Preferred file formats are: Word for Windows, Wordperfect ments on animals which do not fall clearly within the current for Windows. Microsoft Word for Mac. or ASCII. For non laws governing animal experimentation in the United King- electronic submission please supply the manuscript (including dom. Authors must make it clear that the procedures they all Tables and Figures) plus a copy on disk (please label your use were as humane as possible and the doses (initial and disk with the corresponding author’s name, file name and subsequent) of anaesthetics and analgesics should be clearly programme used) stated: the method of assessing anaesthesia, particularly after the administration of skeletal muscle relaxants (neuromusculat blocking drugs). must be well defined litle page The Society has an Ethics Committee which can pe The title should normally contain no more than 150 characters consulted by authors through the Senior Editor to the and should not be interrogative or consist of more than one Editorial Board sentence. It should clearly indicate the subject matter of the When investigations on normal human subjects are paper and any statements contained therein should be justified reported, evidence of approval by a local Ethics Committee by the results presented in the papet \ short running title must be given Papers concerned with clinical trials on containing not more than 50 characters and spaces is also investigations ol the effects of drugs on patients are not required. The title page should include the names of authors appropriate for this Journal and their appropriate addresses. It should be made clear which Authors are strongly urged to keep their manuscripts as iddress relates to which author. Authors’ present addresses short as they reasonably can. An effective way is to reduce differing from those at which the work was carried out should the Discussion and the number of figures to a minimum and be given as footnotes on the title page and references at the to avoid repetition of information that has already been appropriate place in the author list by superscript numbers. A published. Authors should remember that a reader may be footnote may also be used to indicate the author to whom influenced by literary style and will appreciate simple but correspondence should be sent. Please note an email address accurate prose must be given The use of footnotes for any other reason is not It is important to note that failure to comply with illowed. If the email address to which proofs should be sent is ‘Instructions to Authors’ may lead to considerable editorial not that of the first mentioned author, clear instructions should delays. be given in a covering note and not on the title page. The title page should be paginated as page | of the paper Manuscripts can be submitted using the following options: a. Log onto the BJP Website www.brjpharmacol.org and submit to E Journal Press (BJP online submission web page) Summary b. Mail one hard copy accompanied by a disk to the BJP The summary will be printed at the beginning of the paper Editorial Office It must not exceed 250 words and should be intelligible to the Instructions to Authors Discussion The purp Kevwords Acknowledgements \ Abbreviations References B & K Introduction submitted and accepted Viethods Papers in preparation or which have been submitted but not yet finally accepted for publication must not be included in the list of references volume number volume number Results | ; British Journal of Pharmacology Instructions to Authors arabic numerals and the number should be followed b descriptive capuion, occupying not more than two lines head of the table. The proportions of the text area should borne in mind when designing the layout of tables. For the of clarity, tables should not have more than 120 cha line, with spaces between columns counted as four The absolute maximum is 180 characters toa line. Ea should have a heading and the units of measureme given in parentheses in the heading. Except circumstances, tables should be self-explanator descriptions should be at the bottom of the table Figures To avoid unnecessary half-tone reproduction be illustrated. The cost the Author. | pon acceptance ithors t Line Figures their colour charges by th oductior ffi | Please note that the Author - eject a Manuscript Submission Requirements e@ Preferred size for t 160 mm British Journal of Pharmacology Instructions to Authors Lettering labelling should not be too small after reduc- minimise the spaces between each part, without overcrowding ion the entire Figure When graphs ar e generated by computer, lines must not Figure | illustrates a simple properly-drawn graph in its show noticeable stepping original form (a) and in its reduced form (b) as it would some shading may 1ot reproduce after red uction. Please appear in the Journal (single column width) nNaadl e shading as ‘coarse’ as possible The preferred order to shading of histogram columns 1s open (clear), closed , (solid), cross-hatched (lines one way). heavily stippled Photographs and photomicrographs and other (1 f required) The explanation of the symbols and column headings must be These should be submitted, twice as large as their intended given as a key in the Figure itself and not in the Figure legend. published size, as good quality prints of high contrast Line Figures should normally have only left and bottom axes; especially where traces and records are illustrated. When box-style Figures and those using 3-dimensions are not acceptable submitting half-tone illustrations for publication authors Where the Fi gure is a composite of more than one graph. should remember that it is not possible to reproduce Figures experimental record etc., particular care is needed to to a finer quality than the original photographs/photo- DRUG 1 DRUG 2 DRUG 3 DRUG 4 re E c 2 77) Cc —® , i i | 150 200 100 Methylene T(emngs)i on Methylene Figure 1 (a) Artwork as drawn. (b) Artwork reduced to 60 per cent of its original size for publication in the Journal to fit in single column width British Journal of Pharmacology Instructions to Authors micrographs provided. A CALIBRATION BAR MUST BE Up to 8 keywords should be included on the same page as PROVIDED ON THE PHOTOMICROGRAPH to ensure the non-standard abbreviations that, if the Printer reduces the plate, the scale is reduced in \ summary is not required the correct proportion Sub headings to be in italics and should not be numbered Authors are encouraged to include diagrammatic material or even published data records if appropriate Proofs The Review should be between 5000-8000 words One set of page proofs are usually sent electronically as e-mail attachments to the corresponding author for checking. The VIDEO SUBMISSION proofs plus any minor corrections must be returned to the Production Controller by fax or post within 48 hours of receipt The preferred format for video submission is Quicktime Failure to do this will result in delays to the publication. A photocopy of the corrections should be retained by the author SUBMISSION STATEMENT AND AUTHOR LICENCE SPECIAL REPORTS Submission statement The purpose of Special Reports is to provide rapid publication for new and important results which the Editorial Submission of a manuscript will be taken to indicate the Board considers are likely to be of special pharmacological following significance. Special Reports will have publication priority (a) that Authors have obtained permission to publish from over all other material and so authors are asked to consider their employers or institutions, if they have a contrac- carefully the status of their work before submission, and to tual or moral obligation to do so state briefly in the covering letter why they believe their work that approvals are held from any persons acknowledged, deserves priority publication or cited as having provided personal communication; In order to speed publication there is normally no revision that all authors have seen and approved the final version allowed beyond very minor typographical or grammatical of the submitted paper: corrections. If significant revision is required, the Board may that the content of the manuscript is original and that it either invite rapid re-submission or, more probably, propose has not been published or accepted for publication, that it be re-written as a Full Paper and be re-submitted fo either in whole or in part, in any form and consideration. In order to reduce delays, proofs of Special that no part of the manuscript is currently under Reports will be sent to authors but essential corrections must consideration for publication elsewhere reach the Publisher within 48 hours of receipt. Authors should ensure that their submitted material conforms exactly to the Author Licence following requirements Special Reports must occupy no more than four printed Ihe British Pharmacological Society requires that when a pages. One copy of the manuscript plus a copy on disk manuscript is accepted for publication in the Journal, all should be provided. The manuscript should be prepared in a Authors sign the licence granting the British Pharmacological two-column format as follows. Text (divided initt o Summary Society rights in publishing the article (fax and electronic Introduction, Methods, Results. Discussion. Acknowledge- signatures are not acceptable). This indicates that all authors ments and References. maximum of 20, all sub-headings in seen and approved the final accepted version of the bold) should be justified and in Times New Roman (9 pt) he British Pharmacological Society in turn licences Columns should measure no more than 83 mm (width) and yup to publish the article on behalf of 250 mm (length). The Title (18 pt bold), Authors (12 pt bold) and their Affiliation (9 pt) should spread across both the end of these instructions columns. The Summary (9 pt) should measure (width) and should not exceed 150 words (plus Key Abbreviations as for Full Papers). Within this format ABBREVIATIONS AND SYMBOLS no limitation to the number of illustrations (Figure Tables, with legends) allowed Authors must supply ilh tions which are appropriately sized for direct inclusion Journal These should be either 80 mm width (including labelling) to fit single column or 160 mm width wy uses the SI symbols for units axis labelling) to fit double column Authors must en nultiples of units should be used sufficient space is left in the body of the text illustrations with their associated legends. All lett Figures should be in plain sans serif typeface (Univers, 8 pt) Please note that the complete manuscript (including text, cen Figures and Tables prepared as above) must not exceed the milli four printed page maximum. Manuscripts which do not micro conform to these requirements may be returned to authors for amendment without review. REVIEW ARTICLES A review article follows the same format as a full paper with the exception of the following British Journal of Pharmacology instructions to Authors Chemical and biological abbreviations SYMBOLS CHEMICAL AND BIOLOGICAI ABBREVIATIONS Use abbreviations sparingly as extensive use can make the text hard to follow. Lse of solidus DAG DOPA The solidus should be avoided as far as possible and the negative index substituted, e.g. mg kg rather than mg/kg: pmol mm ~ min ‘ rather than pmol/mm min. Physico-chemical quantities British Journal of Pharmacology